The chemical class of HELT Inhibitors encompasses a group of compounds characterized by their potential to modulate the activity of HELT, a basic helix-loop-helix (bHLH) transcription factor involved in crucial biological processes such as neuronal differentiation and gene regulation. This class is not defined by a common chemical structure but rather by a shared functional aim: to influence the role of HELT in transcription regulation and chromatin dynamics. The inhibitors in this class are conceptualized to operate through diverse mechanisms, each targeting different aspects of the transcriptional regulation process in which HELT is a key player.
The primary approach of these inhibitors centers on disrupting the interactions between HELT and the transcription machinery, as well as influencing the chromatin environment where HELT operates. Recognizing that HELT's function as a transcription factor is closely tied to chromatin structure, these inhibitors are designed to modify the epigenetic landscape, thereby indirectly affecting HELT's activity. This includes altering histone modifications, which play a critical role in determining chromatin accessibility and structure. By changing the acetylation or methylation status of histones, these compounds can impact the accessibility of DNA to transcription factors, including HELT. Furthermore, some inhibitors in this class focus on modulating the broader transcriptional machinery, targeting enzymes like RNA polymerase II or components of the ubiquitin-proteasome system, which are integral to the regulation of gene expression and protein turnover in the cell. The exploration of HELT Inhibitors represents an advanced frontier in the field of molecular biology, emphasizing the modulation of key proteins involved in the regulation of gene expression. This class of inhibitors demonstrates the intricate interplay between transcription factors, chromatin structure, and epigenetic modifications, highlighting the complex mechanisms that underlie transcription regulation. The development of these inhibitors provides valuable insights into the fundamental processes of gene expression regulation and the role of transcription factors like HELT in these processes. By focusing on the modulation of HELT and its associated pathways, this class of inhibitors offers a novel perspective on the mechanisms governing transcription and chromatin dynamics, shedding light on the multifaceted nature of transcriptional regulation in cellular and developmental contexts. The study of HELT inhibitors thus serves as a gateway to a deeper understanding of transcription regulation, with potential implications for unraveling the complexities of gene expression in various biological systems.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A increases histone acetylation, potentially altering chromatin structure and indirectly impacting HESL's transcriptional activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Acts as a DNA methyltransferase inhibitor, reducing DNA methylation, which might influence chromatin remodeling and indirectly affect HESL's function in gene regulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, Suberoylanilide Hydroxamic Acid can modify chromatin accessibility, potentially influencing HESL's role in transcription regulation. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
As a histone methyltransferase inhibitor, GDC-0941 can change histone methylation patterns, potentially impacting HESL's involvement in chromatin structure and transcription regulation. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
Selectively inhibits histone acetyltransferase p300, altering chromatin acetylation and structure, which might impact HESL's transcriptional coactivator function. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, reducing transcription levels, thereby indirectly affecting HESL's role in gene regulation. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
As a PARP inhibitor, Olaparib might indirectly affect chromatin dynamics, influencing HESL's function in transcription regulation. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A broad-spectrum histone deacetylase inhibitor, Panobinostat could indirectly influence chromatin remodeling activities and HESL's function. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
As a histone deacetylase inhibitor, MS-275 can impact chromatin structure, potentially influencing HESL's role in transcription regulation. | ||||||
JNJ-26481585 | 875320-29-9 | sc-364515 sc-364515A | 5 mg 50 mg | $321.00 $1224.00 | ||
Another histone deacetylase inhibitor, JNJ-26481585 could affect chromatin structure, potentially impacting HESL's function in gene regulation. | ||||||